NASDAQ:VRPX

Virpax Pharmaceuticals Stock Forecast

etoro logo Buy VRPX
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 28, 2026
Add VRPX to Watchlist?
  • Easy Tracking In The Watchlist

VRPX Performance

FAQ

What is the symbol for Virpax Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Virpax Pharmaceuticals, Inc. is VRPX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virpax Pharmaceuticals, Inc. Stock?
Virpax Pharmaceuticals, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Virpax Pharmaceuticals, Inc. Stock?
Virpax Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virpax Pharmaceuticals, Inc. Stock.

What's the current price of Virpax Pharmaceuticals, Inc. Stock?
As of the end of day on the Jul 28, 2026, the price of an Virpax Pharmaceuticals, Inc. (VRPX) share was $0.0001.

What is the 52-week high and low for Virpax Pharmaceuticals, Inc. Stock?
The 52-week high for Virpax Pharmaceuticals, Inc. Stock is $0.100 and the 52-week low is $0.0001.

What is the market capitalization of Virpax Pharmaceuticals, Inc. Stock?
As of the Jul 28, 2026, the market capitalization of Virpax Pharmaceuticals, Inc. is 124.

When is the next earnings date for Virpax Pharmaceuticals, Inc.?
The upcoming earnings date for Virpax Pharmaceuticals, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT VIRPAX PHARMACEUTICALS, INC.
Virpax Pharmaceuticals
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an inject...
GOLDEN STAR
Ticker Change Signal Date
BIIB
$202.19
1.69% Jul 24
A
AVS
$7.74
0.388% Jul 24
IMMR
$6.60
16.06% Jul 23
S
SW
$43.71
16.22% Jul 23
TSCO
$30.32
3.76% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE